Quince Therapeutics Inc (QNCX)

NASDAQ

$18.78

Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. The company is headquartered in South San Francisco, California.

Website: https://quincetx.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $83.33 (+343.72%)

Market Cap

$13M

Beta (5Y)

0.47

Price Chart

Adjust inflation

Log

Valuation

Market Cap$13M

P/B1.15

Profitability

EBITDA-$58M

EPS-$9.94

Growth & Risk

EPS 5Y CAGR-18.73%

FCF 5Y CAGR-5.90%

Beta (5Y)0.47

Sharpe Ratio0.41